Event Details
European Society of Cardiology (ESC) Congress 2025
Aug 29 - Sep 1, 2025
Title: A Randomized, Placebo-controlled Phase 3 Study of Plozasiran in Patients With FCS: Interim Analysis of Open Label Extension of PALISADE at 1 Year
Date/Time: August 30, 2025, 5:15 pm CET
Type: Moderated Poster Presentation
Title: Safety and Efficacy of Zodasiran, a Hepatic siRNA Targeting ANGPTL3, in Mixed Hyperlipidemia Patients: 2 Year Open Label Extension (OLE) Results from ARCHES-2
Date/Time: August 31, 2025, 8:15 am CET
Presenter: Robert Rosenson Type: Moderated Poster Presentation